Outsourced Pharma Capacity Update Videos - Cell & Gene

  1. Kincell Bio Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Explore how expert CMC strategies and clinical manufacturing experience can lay the groundwork for the successful commercialization of advanced cell therapies.

  2. Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Witness how NYBCe and CCS are transforming cell and gene therapy development with end-to-end CDMO solutions, advanced logistics, and a growing innovation hub in Louisville.

  3. Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    In this presentation, Shaan Gareeb highlights the capabilities of our Cell Therapy Center of Excellence in San Jose, California, one of five global Miltenyi Bioindustry sites.

  4. Optimization-By-Design: A Critical Factor In Viral Vector Scale Up, Scale Down 4/24/2025

    Focusing on critical parameters such as cell culture conditions, viral vector yield, and downstream purification strategies, can drive the success of scale-up and scale-down models for AAV production.

  5. SK pharmteco Capacity Update April 2025: Cell & Gene Therapy 4/24/2025

    Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.

  6. Advancing Cell & Gene Therapies To Patients 4/24/2025

    Discover how we apply our expertise and know-how to efficiently advance your viral vector-based therapeutic through any phase, while enhancing quality and de-risking production.

  7. Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    See how Forge’s dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.

  8. Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    Here we introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development.

  9. Aldevron Capacity Update January 2025: Cell & Gene Therapy 1/30/2025

    In this session, you will discover how Alchemy technology utilizes a cell-free, enzymatic DNA manufacturing process that accelerates linDNA template production, allowing you to expedite your mRNA research and development pipeline.